Insider Transactions in Q4 2020 at Axogen, Inc. (AXGN)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 30
2020
|
Michael Patrick Donovan VP Operations |
SELL
Open market or private sale
|
Direct |
1,733
-6.24%
|
$29,461
$17.48 P/Share
|
|
Dec 29
2020
|
Isabelle Billet Chief Strategy and BD Officer |
SELL
Open market or private sale
|
Direct |
649
-6.4%
|
$11,033
$17.81 P/Share
|
|
Dec 29
2020
|
Maria D. Martinez Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
567
-10.84%
|
$9,639
$17.81 P/Share
|
|
Dec 29
2020
|
Mark Louis Friedman VP Regulatory Affairs & Policy |
SELL
Open market or private sale
|
Direct |
567
-4.85%
|
$9,639
$17.81 P/Share
|
|
Dec 29
2020
|
Karen L. Zaderej CEO |
SELL
Open market or private sale
|
Direct |
3,500
-0.52%
|
$59,500
$17.81 P/Share
|
|
Dec 29
2020
|
Angelo Scopelianos Chief R&D Officer |
SELL
Open market or private sale
|
Direct |
567
-9.3%
|
$9,639
$17.81 P/Share
|
|
Dec 29
2020
|
Peter J Mariani EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,293
-11.08%
|
$21,981
$17.81 P/Share
|
|
Dec 29
2020
|
Gregory Gene Freitag Director |
SELL
Open market or private sale
|
Direct |
916
-0.37%
|
$15,572
$17.81 P/Share
|
|
Dec 29
2020
|
Michael Patrick Donovan VP Operations |
SELL
Open market or private sale
|
Direct |
567
-2.0%
|
$9,639
$17.81 P/Share
|
|
Dec 29
2020
|
Erick Wayne De Vinney Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
371
-0.58%
|
$6,307
$17.81 P/Share
|
|
Dec 27
2020
|
Isabelle Billet Chief Strategy and BD Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,300
+18.48%
|
-
|
|
Dec 27
2020
|
Maria D. Martinez Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,300
+30.54%
|
-
|
|
Dec 27
2020
|
Mark Louis Friedman VP Regulatory Affairs & Policy |
BUY
Grant, award, or other acquisition
|
Direct |
2,300
+16.44%
|
-
|
|
Dec 27
2020
|
Karen L. Zaderej CEO |
BUY
Grant, award, or other acquisition
|
Direct |
8,800
+1.28%
|
-
|
|
Dec 27
2020
|
Angelo Scopelianos Chief R&D Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,300
+27.39%
|
-
|
|
Dec 27
2020
|
Peter J Mariani EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,250
+31.03%
|
-
|
|
Dec 27
2020
|
Gregory Gene Freitag Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,300
+0.91%
|
-
|
|
Dec 27
2020
|
Michael Patrick Donovan VP Operations |
BUY
Grant, award, or other acquisition
|
Direct |
2,300
+7.51%
|
-
|
|
Dec 27
2020
|
Erick Wayne De Vinney Chief Innovation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,500
+2.3%
|
-
|
|
Dec 23
2020
|
Karen L. Zaderej CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
19,375
+2.83%
|
$77,500
$4.81 P/Share
|
|
Dec 22
2020
|
Michael Patrick Donovan VP Operations |
SELL
Open market or private sale
|
Direct |
279
-1.06%
|
$4,743
$17.19 P/Share
|
|
Dec 21
2020
|
Mark Louis Friedman VP Regulatory Affairs & Policy |
SELL
Open market or private sale
|
Direct |
96
-1.07%
|
$1,536
$16.42 P/Share
|
|
Dec 21
2020
|
Peter J Mariani EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
481
-6.97%
|
$7,696
$16.42 P/Share
|
|
Dec 21
2020
|
Michael Patrick Donovan VP Operations |
SELL
Open market or private sale
|
Direct |
96
-0.36%
|
$1,536
$16.42 P/Share
|
|
Dec 21
2020
|
Gregory Gene Freitag Director |
SELL
Open market or private sale
|
Direct |
379
-0.15%
|
$6,064
$16.42 P/Share
|
|
Dec 21
2020
|
Erick Wayne De Vinney Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
147
-0.24%
|
$2,352
$16.42 P/Share
|
|
Dec 21
2020
|
Karen L. Zaderej CEO |
SELL
Open market or private sale
|
Direct |
1,275
-0.2%
|
$20,400
$16.42 P/Share
|
|
Dec 18
2020
|
Mark Louis Friedman VP Regulatory Affairs & Policy |
BUY
Grant, award, or other acquisition
|
Direct |
375
+4.0%
|
-
|
|
Dec 18
2020
|
Peter J Mariani EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,900
+21.59%
|
-
|
|
Dec 18
2020
|
Michael Patrick Donovan VP Operations |
BUY
Grant, award, or other acquisition
|
Direct |
375
+1.4%
|
-
|
|
Dec 18
2020
|
Gregory Gene Freitag Director |
BUY
Grant, award, or other acquisition
|
Direct |
925
+0.38%
|
-
|
|
Dec 18
2020
|
Erick Wayne De Vinney Chief Innovation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
575
+0.92%
|
-
|
|
Dec 18
2020
|
Karen L. Zaderej CEO |
BUY
Grant, award, or other acquisition
|
Direct |
3,125
+0.48%
|
-
|
|
Dec 15
2020
|
Erick Wayne De Vinney Chief Innovation Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,373
-6.62%
|
$69,968
$16.5 P/Share
|
|
Dec 15
2020
|
Erick Wayne De Vinney Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+18.51%
|
$60,000
$4.81 P/Share
|
|
Dec 03
2020
|
Mark Louis Friedman VP Regulatory Affairs & Policy |
BUY
Exercise of conversion of derivative security
|
Direct |
3,812
+18.67%
|
$15,248
$4.24 P/Share
|
|
Nov 09
2020
|
Michael Patrick Donovan VP Operations |
SELL
Open market or private sale
|
Direct |
17,617
-40.36%
|
$264,255
$15.0 P/Share
|
|
Nov 09
2020
|
Karen L. Zaderej CEO |
SELL
Open market or private sale
|
Direct |
14,000
-2.12%
|
$196,000
$14.53 P/Share
|
|
Nov 04
2020
|
Mark Stephen Gold Director |
SELL
Bona fide gift
|
Indirect |
15,596
-5.0%
|
-
|
|
Oct 30
2020
|
Peter J Mariani EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
75,683
-42.77%
|
$908,196
$12.41 P/Share
|
|
Oct 30
2020
|
Peter J Mariani EVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
60,000
+42.65%
|
$300,000
$5.04 P/Share
|